Editor's Note
The Food and Drug Administration (FDA), on June 25, identified the recall of DeRoyal Industries’ surgical procedure packs as Class I, the most serious.
The recall was initiated because the packs contain 1% lidocaine that had been mislabeled as 0.5% bupivacaine.
The procedure packs are used for cardiac procedures, such as heart catheterizations, pacemaker-related procedures, and x-ray imaging (angiogram) procedures.
There have been no deaths, complaints, or reported injuries related to the issue.
Read More >>Left sniffling and sneezing after a whirlwind 4 days at…
Approximately one in 31 hospital patients has at least one…
Anyone doubting the prevalence of workplace violence (WPV) in the…